RG1068 (Synthetic Human Secretin)
RG1068 (Synthetic Human Secretin) is a pharmaceutical drug with 7 clinical trials. Historical success rate of 42.9%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
1
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
42.9%
3 of 7 finished
57.1%
4 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder
Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas
Secretin Enhanced MRCP for Evaluation of Pancreatic Duct in Pediatric Population
Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas
Secretin Enhanced Multidetector CT Pancreatography for Evaluation of Known or Suspected Chronic Pancreatitis
Clinical Trials (7)
Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder
Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas
Secretin Enhanced MRCP for Evaluation of Pancreatic Duct in Pediatric Population
Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas
Secretin Enhanced Multidetector CT Pancreatography for Evaluation of Known or Suspected Chronic Pancreatitis
Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction
Synthetic Human Secretin in Children With Autism
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7